A carregar...
Effects of levetiracetam on astroglial release of kynurenine‐pathway metabolites
BACKGROUND AND PURPOSE: Several preclinical studies have demonstrated the unique profiles of levetiracetam (LEV), inhibits spontaneous absence epilepsy models but does not affect traditional convulsion models; however, the detailed pharmacological mechanisms of action of LEV remain to be clarified....
Na minha lista:
| Publicado no: | Br J Pharmacol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6193875/ https://ncbi.nlm.nih.gov/pubmed/30153331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bph.14491 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|